基于的连接体对抗剂阻断了Vibrio cholerae粘附蛋白
Mingyu Wang1,2, Grace Du1, Charity Yongo-Luwawa3
1Department of Anatomy and Cell Biology, McGill University, Montreal, Canada.
FEBS letters
|November 20, 2025
概括
研究人员开发了新的D-氨基酸,可以有效地阻止Vibrio cholerae粘附于宿主细胞. 这些新型抗粘附是一种有前途的治疗策略,可以对抗霍乱感染.
科学领域:
- 微生物学 微生物学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 霍乱病毒 (Vibrio cholerae) 使用表面蛋白质引起霍乱,例如RTX粘合物FrhA用于宿主殖民.
- 阻止细菌粘附是对抗感染的关键策略,而不会导致耐药性.
- FrhA的结域 (PBD) 对于血液凝结,细胞结合和生物膜形成至关重要.
研究的目的:
- 阐明FrhA-PBD对的识别的分子基础.
- 开发一种新型的,高亲和度的抑制剂来抑制V. cholerae的粘附.
- 推进治疗霍乱和相关感染的抗粘附策略.
主要方法:
- 针对FrhA-PBD的配体的结构导向设计.
- 含有D-氨基酸的三基因的识别和表征.
- 使用纳米分子度测量进行亲和度评估.
主要成果:
- 确定了一种最小的D-氨基酸三基因,对FrhA-PBD的亲和力明显更高.
- 新的体表现出纳米分子亲和力,优于以前的高微分子体.
- 预测的代谢稳定性表明治疗应用的潜力.
结论:
- 这项研究提供了对FrhA-相互作用的分子理解.
- 开发的D-氨基酸代表了一类新的抗粘附疗法.
- 这些发现为下一代抗粘附药物对抗V. cholerae感染提供了结构蓝图.
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
890
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
890
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.0K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.0K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.7K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.7K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
2.7K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.7K


